Stereotaxis: A Medical Robotics Company with Upside Potential to Offset Cash Burn and Execution Risks

Stereotaxis, a medical robotics company, develops devices for minimally invasive endovascular procedures using its Robotic Magnetic Navigation (RMN) platform. The company focuses on electrophysiology and claims to offer advantages in precision and safety over traditional procedures. Stereotaxis has experienced cash burn and execution risks, but its medical robotics upside remains a significant opportunity.